Short-term glucose variability in healthy volunteers is not associated with raised oxidative stress markers

A. Wakil, K. A. Smith, Stephen Atkin, E. S. Kilpatrick

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

It is unknown whether glycaemic variability adds to the risk of microvascular complications of diabetes over and above the mean glucose value for a patient. We examined the effect of purposefully induced short-term glycaemic variability on oxidative stress markers. Eleven healthy subjects underwent three sequential glycaemic states; sustained hyperglycaemia, sustained euglycaemia and variable glycaemia, using glycaemic clamps for 3h. Twenty-four hours urinary 8-isoprostane-PGF2α was measured before and after each glycaemic state to assess oxidative stress. The median and interquartile range of the urinary 8-iso-PGF2α in ng/24h were (1373, 513), (996, 298) and (1227, 472) for the euglycaemic, hyperglycaemic and variable states, respectively. There was no significant difference in urinary isoprostanes between the three different states; mean ranks 20.9, 11.9 and 18.2 for the euglycaemic state, hyperglycaemic state and glycaemic variability state, respectively, p = 0.083. In conclusion, we did not see a significant increase in the urinary isoprostanes when glycaemic variability was induced under controlled conditions in healthy individuals.

Original languageEnglish
Pages (from-to)1047-1049
Number of pages3
JournalDiabetes, Obesity and Metabolism
Volume14
Issue number11
DOIs
Publication statusPublished - Nov 2012
Externally publishedYes

Fingerprint

Isoprostanes
8-epi-prostaglandin F2alpha
Dinoprost
Healthy Volunteers
Oxidative Stress
Glucose
Diabetes Complications
Hyperglycemia

Keywords

  • Diabetes complications
  • Microvascular
  • Somatostatin

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Short-term glucose variability in healthy volunteers is not associated with raised oxidative stress markers. / Wakil, A.; Smith, K. A.; Atkin, Stephen; Kilpatrick, E. S.

In: Diabetes, Obesity and Metabolism, Vol. 14, No. 11, 11.2012, p. 1047-1049.

Research output: Contribution to journalArticle

@article{66eb8123c9b142eb93e86f71c386dadb,
title = "Short-term glucose variability in healthy volunteers is not associated with raised oxidative stress markers",
abstract = "It is unknown whether glycaemic variability adds to the risk of microvascular complications of diabetes over and above the mean glucose value for a patient. We examined the effect of purposefully induced short-term glycaemic variability on oxidative stress markers. Eleven healthy subjects underwent three sequential glycaemic states; sustained hyperglycaemia, sustained euglycaemia and variable glycaemia, using glycaemic clamps for 3h. Twenty-four hours urinary 8-isoprostane-PGF2α was measured before and after each glycaemic state to assess oxidative stress. The median and interquartile range of the urinary 8-iso-PGF2α in ng/24h were (1373, 513), (996, 298) and (1227, 472) for the euglycaemic, hyperglycaemic and variable states, respectively. There was no significant difference in urinary isoprostanes between the three different states; mean ranks 20.9, 11.9 and 18.2 for the euglycaemic state, hyperglycaemic state and glycaemic variability state, respectively, p = 0.083. In conclusion, we did not see a significant increase in the urinary isoprostanes when glycaemic variability was induced under controlled conditions in healthy individuals.",
keywords = "Diabetes complications, Microvascular, Somatostatin",
author = "A. Wakil and Smith, {K. A.} and Stephen Atkin and Kilpatrick, {E. S.}",
year = "2012",
month = "11",
doi = "10.1111/j.1463-1326.2012.01625.x",
language = "English",
volume = "14",
pages = "1047--1049",
journal = "Diabetes, Obesity and Metabolism",
issn = "1462-8902",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Short-term glucose variability in healthy volunteers is not associated with raised oxidative stress markers

AU - Wakil, A.

AU - Smith, K. A.

AU - Atkin, Stephen

AU - Kilpatrick, E. S.

PY - 2012/11

Y1 - 2012/11

N2 - It is unknown whether glycaemic variability adds to the risk of microvascular complications of diabetes over and above the mean glucose value for a patient. We examined the effect of purposefully induced short-term glycaemic variability on oxidative stress markers. Eleven healthy subjects underwent three sequential glycaemic states; sustained hyperglycaemia, sustained euglycaemia and variable glycaemia, using glycaemic clamps for 3h. Twenty-four hours urinary 8-isoprostane-PGF2α was measured before and after each glycaemic state to assess oxidative stress. The median and interquartile range of the urinary 8-iso-PGF2α in ng/24h were (1373, 513), (996, 298) and (1227, 472) for the euglycaemic, hyperglycaemic and variable states, respectively. There was no significant difference in urinary isoprostanes between the three different states; mean ranks 20.9, 11.9 and 18.2 for the euglycaemic state, hyperglycaemic state and glycaemic variability state, respectively, p = 0.083. In conclusion, we did not see a significant increase in the urinary isoprostanes when glycaemic variability was induced under controlled conditions in healthy individuals.

AB - It is unknown whether glycaemic variability adds to the risk of microvascular complications of diabetes over and above the mean glucose value for a patient. We examined the effect of purposefully induced short-term glycaemic variability on oxidative stress markers. Eleven healthy subjects underwent three sequential glycaemic states; sustained hyperglycaemia, sustained euglycaemia and variable glycaemia, using glycaemic clamps for 3h. Twenty-four hours urinary 8-isoprostane-PGF2α was measured before and after each glycaemic state to assess oxidative stress. The median and interquartile range of the urinary 8-iso-PGF2α in ng/24h were (1373, 513), (996, 298) and (1227, 472) for the euglycaemic, hyperglycaemic and variable states, respectively. There was no significant difference in urinary isoprostanes between the three different states; mean ranks 20.9, 11.9 and 18.2 for the euglycaemic state, hyperglycaemic state and glycaemic variability state, respectively, p = 0.083. In conclusion, we did not see a significant increase in the urinary isoprostanes when glycaemic variability was induced under controlled conditions in healthy individuals.

KW - Diabetes complications

KW - Microvascular

KW - Somatostatin

UR - http://www.scopus.com/inward/record.url?scp=84867139608&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867139608&partnerID=8YFLogxK

U2 - 10.1111/j.1463-1326.2012.01625.x

DO - 10.1111/j.1463-1326.2012.01625.x

M3 - Article

VL - 14

SP - 1047

EP - 1049

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

SN - 1462-8902

IS - 11

ER -